13 February 2014 - PHARMAC is seeking feedback on a proposal to fund paliperidone depot injection (Invega Sustenna) from 1 May 2014 in conjunction with a price decrease on risperidone depot injection (Risperdal Consta), both through a provisional agreement with Janssen-Cilag Pty Ltd.

For more details, go to: http://www.pharmac.health.nz/news/consultation-2014-02-13-palperidone/